
JBS Adjusted EBITDA Falls 36% to $1.18 Billion as Net Sales Edge Up 1%
Leverage rose to 3.54x from 2.39x a year earlier, and free cash flow was negative $167 million in the quarter.
JBS N.V. · NYSE · Meat Packing Plants

Leverage rose to 3.54x from 2.39x a year earlier, and free cash flow was negative $167 million in the quarter.
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Aug. 24, 2026 | Guilherme Perboyre Cavalcanti Global CFO and IRO | Sold | 183,501 | $13.85 | $2.54 million |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedJBS N.V. Q3 2026 adjusted EPS of $0.16 falls below consensus; net sales rise 1% to $22.7 billion while adjusted EBITDA drops 36% (IFRS)
Unregistered sales of equity securities · Regulation FD disclosure · Other events · Financial statements and exhibits
AI summary, unreviewedJBS N.V. to Acquire Related-Party Flora for US$542 Million and Canal Rural for US$11 Million, Paid Partly in Treasury Shares to Controlling Shareholder J&F
Other events · Financial statements and exhibits
Regulation FD disclosure · Other events · Financial statements and exhibits